Alexion Pharma (Nasdaq: ALXN) announced that researchers presented new data from an integrated analysis of survival from two ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE